V-meds nano-technology

v-meds nano bots

V-meds are linked to the electronic vaporizer has that has recently come out of the closet since its invention a few decades ago. The aerosol-producing device creates smoke-like residue. The smoke is often referred to as vapour. The liquid mixture is heated by the vaporizer and a fine mist is produced. It is the size of the aerosol particles and the administration technique that interests nano scientists.

Scientists working on the nano scale are hoping to attach molecularly engineered nano medicine to the vapour, as a treatment for illnesses. V-meds or vaporized medicine works on the nano scale, which is very small: 1 nano meter is 1 billionth of a meter.

Engineering V-meds for vaping

Engineering v-meds on this molecular level is obviously very tricky, global spending on nanotech is over 2 billion dollars per annum, this funding from investors is aiding some revolutionary breakthroughs, in both Nano-robotics and v-meds.

V-meds will soon be able to treat many illnesses and aid the bodies own immune system to heal; v-meds will help repair and generate new cells. V-meds will be a specifically targeted treatment for lung, throat and heart diseases and hopefully be a cure for many forms of cancer.

V-medicine or e-medicine containing nano-bots seek out infected or diseased tissue, after the e-medicine has been vaporized and inhaled or administered. It is the heat produced by vaporization that is helping to solve nano-robotic power issues. Nano robots are so small that you can’t even see them but even something this small needs a power source. The heat produced by the battery in order for vaporization is enough to energise the tiny nano-bots and give them enough fuel to perform a specific task. The heat driven nano bots are far more reliable and much less likely to mutate, compared to their chemically powered nano-bot  cousins. Once the task has been completed the bots simply die and are filtered away. Chemically driven nano-bots are far harder for the body to filter.

V-med nano cancer treatment

The specific task might be to target and destroy cancer cells in a living subject, engineered molecule by molecule to seek out and attach itself to infected cells. This area of research is receiving a lot of funding as new reports suggest 1 in 3 of us will get cancer at some stage in our lives.

How this engineering will be done is mind boggling enough, scientists are working through the most powerful microscopes in the world in specifically designed labs to develop this intricate technology. The scientists manipulate single molecules until the nano-bots are smart enough to recognise the difference between a healthy cell and a diseased cell. Scientists have already designed bots that are about 1.5 nano-meters in size, and that are able to count the number of molecules in a cell. Reports often say that these 1.5 nano-meter robots are quite primitive compared with what research has thrown up today.

Scientists claim to have engineered bots that have the ability to change cells by taking a tiny payload of medicine or mineral and attaching themselves to the infected area. Nano bots can work in synchronisation together to perform internal repairs without surgery. There will be no to little pain and few side effects, then once the nano bots work is done they simply die and get filtered by the body.

Vaping medicine safety concerns

There is plenty of concern with regards to the safety of nano-tech and v-meds. The concern arises mainly into the side affects of what these tiny robots might do. A worry is that they might start reproducing and take over the body like some kind of engineered parasite, or make the cancer or illness worse, though the main concern is how the nano-bots will exit the body. Will the planned obsolescence in their blueprint be adhered to? Or will the bots try and hold on to their tiny molecular life? Only research will show.

Some nano bots are being designed to reproduce once ingested, their purpose will be to attack and fight larger areas that require treatment, once the job is done then hopefully the bots planned obsolescence will kick in, if this fails then new v-meds could be administered that are engineered to attack the first lot. If this fails you can see where the concern about nano-bot infestation occurs!

With ever improving technology and knowledge being gained by the nano second, it is quite easy to see a future with nano-botic medicine and vaped v-meds being an everyday occurrence. With planned launches of nano-medicines being announced and new products coming onto the market, nano tech is going to be an invisible future for us all to see!

V-Meds

V-meds is a newly coined phrase referring to vaporized medicine; a new development that moves beyond outdated medical solutions such as Vicks Vaporub, and progresses prescription medicine into the technologically advanced era we live in now. An electronically revolutionised era, where all manner of medicines can be vaporized and inhaled. An era where the hypodermic needle can retire, and painful jabs become a thing of the past.

In 2016 the regulators of the medical world will be taking control of and overseeing e-liquid, e-cigarettes and vaporizers, this making the path to market easier for devices with medical application.

V-meds could soon be sold over the counter in chemists and surgeries, with many brands offering a vaped alternative for treating ailments like influenza and cancer. Vaporizing technology is moving forward at a steady pace with developments in delivery systems making it possible to administer a controlled and measured dose of medicine with each vape.

V-meds: pain relief

Taking traditional tablets such as paracetamol, ibuprofen and aspirin for aches and pains can be a pain in itself; the pills are huge and hard to swallow, they taste fowl if they touch your tongue, and most annoyingly you have to wait up to half an hour to see any effect. The new method of vaporizing medicines, even commonplace painkillers, can eliminate all three of the hassles mentioned above.

A convenient use for the advancement of vaping medicine is the regular use of painkillers, that could now become instantly effective and simple to deliver a specific controlled dose.

V-meds: cannabis

With the emergence of vaporizing technology as an aid to quit smoking tobacco, there was a realization that other substances can be vaped as a healthier, less intrusive way of medicine administration. Take cannabis for example, in its many forms marijuana has been hailed as a natural cure for some diseases and as a natural form of pain relief. Before vaporizing, cannabis would have been taken orally or smoked; you can also eat cannabis, which is not known to harm the body but takes longer to take effect, as it has to be digested.

Most people know that smoking cannabis is harmful, particularly when rolled with tobacco, and that many gases contained in the smoke are harmful and over time can cause other illnesses. Vaping in the form of v-meds offers a healthier alternative to smoking; none of the harmful gases are released when cannabis is vaporized. When cannabis is vaporized it gets into the bloodstream much quicker compared to ingestion, offering a quicker and more targeted form of pain relief.

V-meds: cancer treatment

In the future, v-med applications could include headache and migraine relief, replacing traditional pills and powders. Heating the medicine before administration also creates a whole new avenue of research into flu and cold treatment, could it be that with v-medicine technology we finally find a cure for the common cold?

Cancer treatment is also another particularly important potential application for v-meds, and some of the many drugs taken to combat cancer could be vaped instead of ingested or injected. Anyone who has had cancer treatment or knows someone that has been through the ordeal, knows that swallowing 20+ pills per day can be tough in itself. Vaping some, if not all, of the medicine is a possibility that’s far less taxing for an extremely ill person.

Taking cannabis oils as a treatment for cancer is a method that some people swear by, vaping the cannabis oil makes this method much less harmful compared to burning and smoking the oils. More and more people are trying alternative treatments, and providing sufferers with a safer means of administering treatments is something pharmaceutical manufacturers should be making a priority.

Medicinal E-liquid

Medicinal e-liquid, nicotine-free e-liquid, administered via an electronic vaping device, is next on the agenda for the think-tanks of the e-smoking industry. Vapeable medicines to treat all manner of ailments are set to revolutionise not only the e-smoking industry, but pharmacology as well.

What we are witnessing currently is a titanic battle between two real super powers: pharmacological corporations, that effect the decisions of governments and push laws through to suit their fields of involvement, and the titans of the tobacco trade whose power and influence far outreaches the mere cigarette between your fingers. The tobacco giants are involved in a complexly intertwined world of regulatory back-scratching with high-level government and adjusted tax levels supposedly in the public’s best interest. So will medicinal e-liquid be any different?

No medicine licence for tobacco firms

It’s not news that tobacco smoking has been targeted with tougher regulations, which have been pushed through by many governments globally in recent years. The banning of smoking in public places has had a social impact and in many cases created a shift in attitude towards tobacco puffers.The trend of harsher regulations suggests that tobacco companies will not be granted a medicinal licence to allow them to trade in e-smoking products.

The e-smoking industry at first was a major threat to tobacco companies, who had been operating successfully and untouched for years. The tobacco firms combated that initial threat by themselves investing heavily in the new electronic smoking industry. However, the move to medical-grade equipment, regulated under the strict and watchful eye of the government and medical officials, will be a change that tobacco companies will struggle to adapt to.

Pharmaceutical E-liquid

Although no information has been released about who will be able to produce pharmaceutical e-liquid post-2016 regulation, it has been announced that any company that wishes to produce and distribute e-liquid must operate under a medicinal licence. Companies that already hold a medicine licence need not worry. This could lead to tobacco companies trying to purchase smaller pharmaceutical companies in a bid to secure themselves a position in this newly heavily-regulated industry.

Actions like this have been seen in the past and are not uncommon nor illegal, it is highly likely that tobacco firms will take this measure to try and steal their share of the market. Whether the MHRA and other regulators allow this to happen, the issuing of medicine licences to tobacco firms will be one that’s contentious and no-doubt contested by the medical world and healthcare professionals. Only the future will tell and time will display the results.

When can I buy E-medicine or V-meds ?

When can I buy E-medicine

E-medicines will be available to buy following regulations in 2016 – exactly when depends on clinical trials and research findings. However, some unregulated products may be available for sale sooner than that over the internet. Though no announcements have been made, and there are few companies advertising e-medicine as an alternative treatment for flu or headaches, it is sure to be available as an alternative treatment at some time in the future. You will be able to vape e-meds at some point within the decade.

Where can I buy E-medicine?

E-medicine post-regulation in 2016 could be available to buy anywhere over the counter from chemists to newsagents. It could and most likely will be available on the NHS via prescription, not only as an aid to quit smoking but also as a treatment for a number of ailments including lung disease and migraines.

Although advertising and sponsorship could be halted, internet sales should remain available and functioning under a medicinal licence. In some cases, buying e-meds will be free if prescribed, if you have no prescription you will be able to buy e-medicines from pharmacies or online retailers. E-meds could and probably will be offered as part of health insurance schemes, part of a healthier lifestyle plan. Most people see vaping as a much healthier alternative to smoking tobacco. Although insurers are treating people that vape e-liquid the same as they do tobacco smokers, which is causing debate as to the safety of e-cigs and other vaping products.

If insurers refuse to see the health benefits of vaping compared to smoking tobacco (if any), then there will be no reduction in the cost of a vapers monthly health care bill. It is causing quite a quandry to both insurers and vapers.

Vaping e-medicines

Electronic smoking: vaping, atomizing or vaping e-medicines is not only a possible future for treating illness, it is a reality for every current person who vapes. Announcements have been made that e-liquid sale and distribution will be regulated as a medicines by the Medicines and Healthcare products Regulatory Agency (MHRA).

The MHRA

The MHRA will be the body too oversee the regulation of vaping e-medicines, reporting back to the UK government on findings regarding the safety of both e-liquid and vaping devices.
The MHRA is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe.
The MHRA also umbrellas the National Institute for Biological Standards and Control (NIBSC) and the Clinical Practice Research Datalink (CPRD); the MRHA is the executive agency for the Department of Health.

An account of the three agencies’ role is outlined here by MHRA chief executive Ian Hudson in this so-called transparency video. It is worth noting the roles and the field of expertise that the other two agencies bring – the NIBSC and CPRD – as they will also play a hand in the overall regulatory decisions expected in 2016.

E-cigs Regulated as Medicine

The current reasons being given for the MHRA regulations are to do with product safety of e-liquid and vaping devices, as well as to try and tackle the problem of under aged smokers picking up the habit.

“ This move has been widely welcomed by medical experts and officials, as tighter regulation will ensure the products are safe and effective. Until this happens, e-cigarettes are only covered by general product safety legislation, meaning they can legally be promoted and sold to children, and we cannot be sure of their ingredients or how much nicotine they contain. The MHRA will not ban the products entirely during this interim period, but will encourage e-cigarette manufacturers to apply for a medicine licence.” (source)

Above is a statement made on the official NHS website explaining the reasons for, and initial effects of the proposed regulation of e-cig manufacturing and sale as medicinal products.

Post 2016, E-cigarette medicine licence

After the 2016 regulations come into affect, and with medicine licenses in hand, e-smoking manufactures could theoretically carry on with the sale of regulated vaporizing products. The medicinal licence makes it easier for other e-medicines such as vaped Ibuprofen and Paracetamol to come onto the market as the MHRA and NIBSC already regulate this industry. This partnership would speed up safety research and decision making into e-meds as there would be no requirement for extra licences.

E-medicine Revolution

Although little information has been released about e-medicine trials, research has been conducted using vaporizing technology as treatment for illness. Vaping medicines as treatment for flu, migraines and even cancer could be a social norm post-2016. Providing regulations and medicinal licences allow the development of e-medicine.

The evolution of vaporizing subsequently opens the door to pharmaceutical giants such as GlaxoSmithKline (GSK) to compete in the vaping market. They would compete alongside the tobacco giants heading up the current marketplace, for example Philip Morris who have invested millions in electronic smoking and have bought out many smaller e-cig brands in a bid to secure their position as an international multi-corporate organisation.

Controlling Electronic Smoking

Control of this lucrative industry will be hard fought and most likely littered with allegations of bribery and corruption. When the free market links with the regulators, and government announces the results, it will be interesting to see where the vested interests of the decision makers lie.

Complete public transparency and a full public investigation prior to 2016 regulation is required as a matter of public interest. That in itself is a mammoth task as data transparency and corporate information is often very hard to obtain. It is difficult to know who will benefit from the law and product changes, but it is likely to include some current politicians and other members of parliament who have vested interests in.